Clinical significance of chromatin remodeling factor CHD5 expression in gastric cancer.

biomarker chromatin remodeling factor chromodomain helicase DNA-binding 5 gastric cancer immunohistochemistry

Journal

Oncology letters
ISSN: 1792-1074
Titre abrégé: Oncol Lett
Pays: Greece
ID NLM: 101531236

Informations de publication

Date de publication:
Jan 2020
Historique:
received: 03 06 2019
accepted: 08 10 2019
entrez: 4 1 2020
pubmed: 4 1 2020
medline: 4 1 2020
Statut: ppublish

Résumé

Chromodomain helicase DNA-binding 5 (

Identifiants

pubmed: 31897220
doi: 10.3892/ol.2019.11138
pii: OL-0-0-11138
pmc: PMC6924149
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1066-1073

Informations de copyright

Copyright © 2020, Spandidos Publications.

Références

Ann Gastroenterol Surg. 2017 Apr 25;1(1):5-10
pubmed: 29863129
J Clin Neurosci. 2013 Jul;20(7):958-63
pubmed: 23707602
Oncotarget. 2016 Apr 19;7(16):21618-30
pubmed: 26943038
J Natl Cancer Inst. 2008 Jul 2;100(13):940-9
pubmed: 18577749
Clin Chim Acta. 2013 Sep 23;424:53-65
pubmed: 23669186
Mol Cancer. 2010 Oct 15;9:277
pubmed: 20950435
Gastric Cancer. 2019 Jul;22(4):785-792
pubmed: 30617648
Gene. 2017 Jun 30;618:65-68
pubmed: 28400267
CA Cancer J Clin. 2015 Mar;65(2):87-108
pubmed: 25651787
Nat Med. 2016 Feb;22(2):128-34
pubmed: 26845405
Lancet. 2010 Aug 28;376(9742):687-97
pubmed: 20728210
Int J Mol Med. 2018 Jan;41(1):155-163
pubmed: 29115379
Oncogene. 2003 Feb 20;22(7):1002-11
pubmed: 12592387
Oncogene. 2014 Nov 20;33(47):5450-6
pubmed: 24276239
Lancet Gastroenterol Hepatol. 2018 Jul;3(7):460-468
pubmed: 29709558
Gastric Cancer. 2011 Jun;14(2):101-12
pubmed: 21573743
Lung Cancer. 2012 Jun;76(3):324-31
pubmed: 22186629
Gynecol Obstet Invest. 2011;72(3):203-7
pubmed: 21860208
Oncotarget. 2015 Dec 1;6(38):40940-52
pubmed: 26517514
J Biomed Sci. 2009 Oct 19;16:95
pubmed: 19840376
Cell. 2007 Feb 9;128(3):459-75
pubmed: 17289567
Arch Pathol Lab Med. 2015 Apr;139(4):457-68
pubmed: 25333834
Epigenetics. 2008 Jul-Aug;3(4):210-5
pubmed: 18698156
Breast Cancer Res. 2012 May 08;14(3):R73
pubmed: 22569290
Oncogene. 2008 Jan 31;27(6):803-10
pubmed: 17667943
Biochemistry. 2012 Aug 21;51(33):6534-44
pubmed: 22834704
Cancer. 2014 Jan 15;120(2):172-80
pubmed: 24243398
Cancer Res. 2014 Feb 1;74(3):652-8
pubmed: 24419087
Cancer Sci. 2017 Oct;108(10):2052-2060
pubmed: 28746773
Oncotarget. 2016 Mar 29;7(13):15977-85
pubmed: 26895110
JMA J. 2018 Sep 28;1(1):40-49
pubmed: 33748521

Auteurs

Tadayoshi Hashimoto (T)

Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan.

Yukinori Kurokawa (Y)

Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan.

Noriko Wada (N)

Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan.

Tsuyoshi Takahashi (T)

Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan.

Yasuhiro Miyazaki (Y)

Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan.

Koji Tanaka (K)

Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan.

Tomoki Makino (T)

Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan.

Makoto Yamasaki (M)

Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan.

Kiyokazu Nakajima (K)

Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan.

Masaki Mori (M)

Department of Surgery and Science, Kyushu University Graduate School of Medical Sciences, Fukuoka 812-8582, Japan.

Yuichiro Doki (Y)

Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan.

Classifications MeSH